SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 26 of 100
Newsletters
The delta between the Delta variants
By
Sy Mukherjee
June 24, 2021
Health
Pressure mounts on Biden to nominate permanent FDA head as dissatisfaction with agency grows
By
Sy Mukherjee
June 22, 2021
Tech
British A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company
By
Jeremy Kahn
June 15, 2021
Health
Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By
Sy Mukherjee
June 9, 2021
Health
Cassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer
By
Cristin Flanagan
and
Bloomberg
June 9, 2021
Health
Amazon begins offering six-month prescriptions for as low as $6
By
Chris Morris
June 8, 2021
Health
FDA approves Biogen’s controversial Alzheimer’s drug in historic decision
By
Sy Mukherjee
June 7, 2021
Health
President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By
Sy Mukherjee
May 25, 2021
Health
Colorado lawmakers wage multi-front assault on high drug costs
By
Markian Hawryluk
and
Kaiser Health News
May 24, 2021
Health
Will AbbVie, maker of the world’s best-selling drug, finally face the music over its price hikes?
By
Sy Mukherjee
May 19, 2021
Commentary
Making cancer treatments affordable today won’t hurt tomorrow’s innovation
By
Rena Conti
,
Richard Frank
and
Leslie Dach
May 12, 2021
Health
Independent pharmacies are fighting to stay in business through the pandemic
By
Markian Hawryluk
and
Kaiser Health News
April 29, 2021
Features
GoodRx helps people afford drugs. But is it improving health care or profiting off a broken system?
By
Erika Fry
April 29, 2021
Conferences
Moderna is working toward a single shot for both COVID and flu protection
By
Sy Mukherjee
April 27, 2021
Newsletters
Would a free water bottle convince you to get a COVID vaccine?
By
Sy Mukherjee
April 26, 2021
Most Popular
Success
Zoom’s CEO agrees with Bill Gates, Jensen Huang, and Jamie Dimon: A 3-day workweek is coming soon thanks to AI
By
Emma Burleigh
Success
Meet a 23-year-old electrician who was a 'good student' but skipped college to join Gen Z's blue-collar revolution. He...
By
Nick Lichtenberg
Personal Finance
Milestones like marriage and parenthood are so delayed for millennials and Gen Z many of them are skipping out on life...
By
Sydney Lake